Public Profile

Lek d. d.

Lek d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has been a key player in the industry since its establishment in 1946. With a strong presence in Central and Eastern Europe, Lek d.d. focuses on the development, production, and marketing of generic and innovative medicines, particularly in the fields of oncology, cardiovascular health, and central nervous system disorders. Renowned for its commitment to quality and innovation, Lek d.d. offers a diverse portfolio of products that cater to various therapeutic areas. The company has achieved significant milestones, including its integration into the Sandoz division of Novartis, enhancing its market position and global reach. Lek d.d. continues to be recognised for its contributions to healthcare, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Lek d. d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Lek d. d.'s score of 38 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

Lek d. d.'s reported carbon emissions

In 2023, Lek d.d. reported carbon emissions of approximately 42,900 kg CO2e for Scope 1, 19,070 kg CO2e for Scope 2, and 1,483 kg CO2e for Scope 3. This marks a significant reduction in emissions compared to previous years, showcasing a commitment to sustainability. For instance, in 2022, emissions were about 59,500 kg CO2e (Scope 1), 26,120 kg CO2e (Scope 2), and 3,102 kg CO2e (Scope 3). Over the years, Lek has demonstrated a consistent downward trend in emissions, particularly in Scope 1 and Scope 2, indicating effective management of direct and indirect emissions. However, there are currently no specified reduction targets or climate pledges documented, which suggests that while Lek is actively reducing emissions, formal commitments to future reductions have not been established. Overall, Lek d.d. is making strides in reducing its carbon footprint, aligning with industry standards for climate action and sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520162017201820192020202120222023
Scope 1
29,585,000
00,000,000
0,000,000
0,000,000
0,000,000
0,000,000
000,000
000,000
00,000
00,000
00,000
Scope 2
27,001,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000
00,000
00,000
00,000
00,000
Scope 3
-
-
00,000,000
00,000,000
00,000,000
00,000,000
0,000
0,000
0,000
0,000
0,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lek d. d.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lek d. d. is in SI, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lek d. d. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

STADA Arzneimittel Aktiengesellschaft

DE
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Gedeon Richter

HU
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Krka

SI
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers